The Market Regime Indicator (MRI) is a proprietary macro indicator developed by State Street Global Advisors’ Investment Solutions Group (ISG). Based on forward-looking market information, it is designed to identify the level of risk aversion/appetite in the market. The factors utilized to generate the signal include implied equity and currency volatility as well as spreads on fixed income.
ISG uses the MRI as one of the inputs into its global Tactical Asset Allocation decision-making process. The MRI is the result of over 12 months of rigorous testing by the Investment Solutions Group. The test results show that the MRI tracked historical market stress events and trading strategies based on the level of outperformance generated by the indicator. By design, the MRI signal varies between 0% and 100%. On this scale, a high level is often characterised by market tensions, such as a significant increase in volatility and a drop in risky asset prices.
Crisis (level close to 100%) — Extreme risk aversion (‘Fear/Panic’)
High Risk Aversion (level above the average) — Aversion toward risky assets
Normal (level oscillating around the mean) — Characterized by neutral market sentiment
Low Risk Aversion (level below the average) — Appetite toward risky assets
Euphoria (level close to 0%) — Extreme risk appetite (‘Greed/Complacency’)
Figure 1: Market Regime Indicator
Figure 2: MRI Evolution
2023 opened with the MRI in Normal risk regime, with the prior quarter having seen the signal broadly trend lower. This continued in January, as early in the month the MRI moved into Low Risk regime, where it remained throughout February. This was the MRI’s first sustained period in Low Risk regime since September 2021, with December having only a fleeting move before the signal reverted to Normal regime. March initially saw the MRI remain stable until a banking crisis saw the signal move quickly higher into Normal regime, and to the cusp of High Risk regime. However, remarkably quickly, the signal again reversed, and by the end of the quarter the MRI was back in Low Risk regime.
The Implied Volatility on Equities factor began the period in Low Risk regime and moved lower in January as markets got the year off to a largely positive start. Inflation continued to be the main theme driving sentiment, and encouraging readings from Germany and France early in the month helped the ‘peak inflation’ narrative.
Additionally a weak services ISM, the lowest since the Global Financial Crisis, was an indication that the US economy was slowing, and could be a further catalyst for less aggressive central bank hikes. Equity markets moved higher against this backdrop, and the Implied Volatility on Equities factor moved lower into Euphoria regime. February initially saw the factor remain in Euphoria regime, with markets latching on to comments by the US Federal Reserve (Fed) Chairman Jerome Powell, who said that ‘the disinflationary process, the process of getting inflation down, has begun’, and Christine Lagarde, President of the European Central Bank, who stated that risks to the inflation outlook were now ‘more balanced’. The second half of the month, however, saw increasingly hawkish central bank rhetoric, alongside data which pointed to continued price pressures. This knocked markets and the factor moved higher into Low Risk regime.
March saw the Implied Volatility on Equities factor initially move lower back into Euphoria regime but this was short-lived as a potential banking crisis took center stage. The trigger was the collapse of Silicon Valley Bank, the 16th largest bank in the US, in March, with the fallout leading to the demise and consequent sale of Credit Suisse. The factor moved quickly higher into the Low Risk and then Normal regime. However, a prompt and decisive response from policymakers, in which central banks in the US, Canada, England, Japan, the European Union and Switzerland joined in a coordinated action to enhance market liquidity, provided some reassurance to the markets. In addition, inflation data in the latter part of the month was softer than anticipated, with equities recovering somewhat and the factor moving back lower into Low Risk regime.
The Implied Volatility on Currencies factor started the year in Normal regime, and, as in the previous quarter, was broadly the most elevated of the three MRI inputs due to considerable central bank uncertainty.
The Japanese yen was central to this in January as early in the month the currency strengthened amid speculation that the Bank of Japan (BoJ) would allow interest rates to rise even further. However, the Japanese currency later slumped against the US dollar after the BoJ surprised markets by keeping its yield curve tolerance band unchanged. February saw the factor move lower, into Low Risk regime, where it remained until the banking turmoil of March, which resulted in the factor moving back to Normal regime. In late March, with rate hikes in line with expectations from the ECB, the Fed and the Bank of England, and some optimism broadly returning to markets, the factor moved lower into Low Risk regime, where it remained till the end of the period.
The Risky Debt Spread factor entered the quarter in Normal regime before moving into Low Risk regime in early January, largely due to a compression in high yield (HY) spreads. The factor continued to trend down, reaching a low in early March, at which point both emerging market debt (EMD) spreads and HY spreads were at their tightest levels since last spring. However, the rapid fall of SVB triggered a broad reassessment of credit risk and pricing across the range of corporate credit quality, with HY and EMD spreads moving to their widest levels of the year and the factor moving quickly into High Risk regime. The quarter closed with the Risky Debt Spread factor in Normal regime, having moved marginally lower.
For investment professional use only.
This document is confidential. It is intended only for the person to whom it is addressed. These materials are only meant for qualified/institutional clients and are not meant for retail distribution. Clients should conduct their own due diligence on the SSSAFS and the financial services marketed. If you do not understand the contents of this document you should consult
an authorized financial adviser.
Investing involves risk including the risk of loss of principal.
The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without SSGA’s express written consent.
Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.
Bonds generally present less short-term risk and volatility than stocks, but contain interest rate risk (as interest rates rise bond prices usually fall); issuer default risk; issuer credit risk; liquidity risk; and inflation risk. These effects are usually pronounced for longer-term securities. Any fixed income security sold or redeemed prior to maturity may be subject to a substantial
gain or loss.
SSGA uses quantitative models in an effort to enhance returns and manage risk. While SSGA expects these models to perform as expected, deviation between the forecasts and the actual events can result in either no advantage or in results opposite to those desired by SSGA. In particular, these models may draw from unique historical data that may not predict future trades or market performance adequately. There can be no assurance that the models will behave as expected in all market conditions. In addition, computer programming used to create quantitative models, or the data on which such models operate, might contain one or more errors. Such errors might never be detected, or might be detected only after the Portfolio has sustained a loss (or reduced performance) related to such errors. Availability of third-party models could be reduced or eliminated in the future.
The views expressed in this material are the views of Investment Solutions Group through the period ended 31 March 2023, and are subject to change based on market and other conditions. All information is from SSGA unless otherwise noted and has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. There is no representation or warranty as to the current accuracy, reliability or completeness of, nor liability for, decisions based on such information and it should not be relied on as such. This document contains certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected.
The information contained in this communication is not a research recommendation or ‘investment research’ and is classified as a ‘Marketing Communication’ in accordance with the Markets in Financial Instruments Directive (2014/65/EU) or applicable Swiss regulation. This means that this marketing communication (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research.
This communication is directed at professional clients (this includes eligible counterparties as defined by the appropriate EU regulator or applicable Swiss Regulator) who are deemed both knowledgeable and experienced in matters relating to investments. The products and services to which this communication relates are only available to such persons and persons of any other description (including retail clients) should not rely on this communication.
The information provided does not constitute investment advice and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any investor’s particular investment objectives, strategies, tax status or investment horizon. You should consult your tax and financial advisor. Past performance is not a guarantee of future results.
© 2023 State Street Corporation. All Rights Reserved.
Exp. Date: 04/30/2024